BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15475069)

  • 1. Association of CYP3A4 genotype with detection of Vgamma/Jbeta trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patients undergoing chemotherapy for ALL.
    Lopes LF; Piccoli Fde S; Paixão VA; Latorre Mdo R; Camargo Bd; Simpson AJ; Caballero OL
    Leuk Res; 2004 Dec; 28(12):1281-6. PubMed ID: 15475069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
    Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
    Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Vgamma/Jbeta trans-rearrangements in paediatric patients undergoing chemotherapy.
    Lopes LF; Dias Neto E; Lorand-Metze I; Latorre MR; Simpson AJ
    Br J Haematol; 2001 Jun; 113(4):1001-8. PubMed ID: 11442495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.
    DeMichele A; Aplenc R; Botbyl J; Colligan T; Wray L; Klein-Cabral M; Foulkes A; Gimotty P; Glick J; Weber B; Stadtmauer E; Rebbeck TR
    J Clin Oncol; 2005 Aug; 23(24):5552-9. PubMed ID: 16110016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN).
    Atanasova SY; von Ahsen N; Toncheva DI; Dimitrov TG; Oellerich M; Armstrong VW
    Clin Biochem; 2005 Mar; 38(3):223-8. PubMed ID: 15708542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
    Pakakasama S; Mukda E; Sasanakul W; Kadegasem P; Udomsubpayakul U; Thithapandha A; Hongeng S
    Am J Hematol; 2005 Jul; 79(3):202-5. PubMed ID: 15981231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional gene variants of CYP3A4.
    Werk AN; Cascorbi I
    Clin Pharmacol Ther; 2014 Sep; 96(3):340-8. PubMed ID: 24926778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia.
    Fleury I; Primeau M; Doreau A; Costea I; Moghrabi A; Sinnett D; Krajinovic M
    Am J Pharmacogenomics; 2004; 4(5):331-41. PubMed ID: 15462611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients.
    Lepper ER; Baker SD; Permenter M; Ries N; van Schaik RH; Schenk PW; Price DK; Ahn D; Smith NF; Cusatis G; Ingersoll RG; Bates SE; Mathijssen RH; Verweij J; Figg WD; Sparreboom A
    Clin Cancer Res; 2005 Oct; 11(20):7398-404. PubMed ID: 16243813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
    Gervasini G; García-Martín E; Ladero JM; Pizarro R; Sastre J; Martínez C; García M; Diaz-Rubio M; Agúndez JA
    BMC Cancer; 2007 Jul; 7():118. PubMed ID: 17605821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of CYP3A4: CYP3A4*18 allele is found in five healthy Malaysian subjects.
    Ruzilawati AB; Suhaimi AW; Gan SH
    Clin Chim Acta; 2007 Aug; 383(1-2):158-62. PubMed ID: 17601520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP3A4 genetic polymorphisms on the genotoxicity of 4,4'-methylene-bis(2-chloroaniline)-exposed workers.
    Wang CC; Chen WL; Hsiung CN; Chiang ST; Wang YC; Loh CH; Lin IS; Chen HI; Liou SH
    Occup Environ Med; 2017 Jan; 74(1):30-38. PubMed ID: 27679675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications.
    Kelly KM; Perentesis JP;
    Ann Oncol; 2002; 13 Suppl 1():34-9. PubMed ID: 12078900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique CYP3A4 genetic variant in Brazilian tuberculosis patients with/without HIV.
    Jeovanio-Silva AL; Monteiro TP; El-Jaick KB; do Brasil PE; Rolla VC; de Castro L
    Mol Med Rep; 2012 Jan; 5(1):153-61. PubMed ID: 21964586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests.
    Lee SJ; Goldstein JA
    Pharmacogenomics; 2005 Jun; 6(4):357-71. PubMed ID: 16004554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles.
    Rodríguez-Antona C; Sayi JG; Gustafsson LL; Bertilsson L; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 2005 Dec; 338(1):299-305. PubMed ID: 16171783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
    Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
    Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
    Hesselink DA; van Schaik RH; van der Heiden IP; van der Werf M; Gregoor PJ; Lindemans J; Weimar W; van Gelder T
    Clin Pharmacol Ther; 2003 Sep; 74(3):245-54. PubMed ID: 12966368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.